13-32370604-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000059.4(BRCA2):​c.8487+47C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,574,010 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.014 ( 38 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 44 hom. )

Consequence

BRCA2
NM_000059.4 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:11

Conservation

PhyloP100: -0.397

Publications

6 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 13-32370604-C-T is Benign according to our data. Variant chr13-32370604-C-T is described in ClinVar as Benign. ClinVar VariationId is 126179.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0137 (2083/152190) while in subpopulation AFR AF = 0.0475 (1971/41502). AF 95% confidence interval is 0.0457. There are 38 homozygotes in GnomAd4. There are 966 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 38 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.8487+47C>T
intron
N/ANP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.8487+47C>T
intron
N/ANP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.8487+47C>T
intron
N/ANP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.8487+47C>T
intron
N/AENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.8487+47C>T
intron
N/AENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.8118+47C>T
intron
N/AENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.0137
AC:
2082
AN:
152072
Hom.:
38
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0476
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00452
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00907
GnomAD2 exomes
AF:
0.00355
AC:
852
AN:
240012
AF XY:
0.00259
show subpopulations
Gnomad AFR exome
AF:
0.0453
Gnomad AMR exome
AF:
0.00285
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000471
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.00304
GnomAD4 exome
AF:
0.00147
AC:
2094
AN:
1421820
Hom.:
44
Cov.:
26
AF XY:
0.00128
AC XY:
905
AN XY:
709134
show subpopulations
African (AFR)
AF:
0.0475
AC:
1541
AN:
32472
American (AMR)
AF:
0.00306
AC:
135
AN:
44112
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25844
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39330
South Asian (SAS)
AF:
0.0000942
AC:
8
AN:
84952
European-Finnish (FIN)
AF:
0.0000943
AC:
5
AN:
53026
Middle Eastern (MID)
AF:
0.00369
AC:
21
AN:
5698
European-Non Finnish (NFE)
AF:
0.000174
AC:
187
AN:
1077386
Other (OTH)
AF:
0.00334
AC:
197
AN:
59000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
98
195
293
390
488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0137
AC:
2083
AN:
152190
Hom.:
38
Cov.:
32
AF XY:
0.0130
AC XY:
966
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0475
AC:
1971
AN:
41502
American (AMR)
AF:
0.00451
AC:
69
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68018
Other (OTH)
AF:
0.00898
AC:
19
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
104
209
313
418
522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00220
Hom.:
5
Bravo
AF:
0.0152
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
Breast-ovarian cancer, familial, susceptibility to, 2 (5)
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Familial cancer of breast (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.25
DANN
Benign
0.68
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11571744; hg19: chr13-32944741; COSMIC: COSV66449045; API